Funding Opportunities
Research Grants on Education: Small
The Small Research Grants on Education Program supports education research projects that will contribute to the improvement of education, broadly conceived, with budgets up to $50,000 for projects ranging from one to five years. We accept applications three times per year. This program is “field-initiated” in that proposal submissions are not in response to a specific request for a particular research topic, discipline, design, method, or location. Our goal for this program is to support rigorous, intellectually ambitious and technically sound research that is relevant to the most pressing questions and compelling opportunities in education.
Due date: 30 April 2024
For more information click: https://www.spencer.org/grant_types/small-research-grant
Cures Within Reach: 2024 ReGRoW: Funding for Underresourced Researchers in Low and Lower-Middle Income Countries
Cures Within Reach has released a new request for proposal (RFP) for projects in any unsolved disease and must repurpose an existing off-patent drug, off-patent device, nutraceutical and/or indigenous medicine in a new indication.
Letters of intent due: 2 May, 2024
For more information, click: https://www.cureswithinreach.org/programs/funding-opportunities-rfps/
Pfizer Independent Medical Education: Diagnosis and Diagnostic Tests for Metallo-βLactamase (MBL) Producing Bacterial Infections
This competitive program aims to foster healthcare professional education to support them in making evidence-informed decisions in the diagnosis and management of patients with Metallo-β-Lactamase (MBL) producing bacterial infections.
Deadline: 15 May 2024
Advancing The Use of Oral Anticoagulants in Atrial Fibrillation and Venous Thromboembolism
Pfizer and Bristol-Myers Squibb (BMS) are collaborating to provide grant support for continuing professional education in the areas of anticoagulation in atrial fibrillation and venous thromboembolism. We are committed to supporting innovative, independent medical education for healthcare professionals.
Deadline: 6 May 2024
Call for letters of interest: Addressing neglected areas of sexual and reproductive health and rights in sub-Saharan Africa (ANSRHRA)
Canada’s International Development Research Centre (IDRC) and other funding partners are investing up to CAD19.1 million to fund up to 16 implementation research teams to support gender-transformative implementation research in sub-Saharan Africa. The ANSRHRA Initiative will prioritize projects that address the following five priority areas of sexual and reproductive health and rights (SRHR):
- improving access to family planning and contraceptive services
- expanding access to safe abortion where legally permitted and post-abortion care
- upholding SRHR rights and ensuring access to services for adolescents
- preventing and improving services for people experiencing sexual and gender-based violence
- strengthening advocacy for SRHR
Successful projects will address at least one of these priority areas of SRHR.
Deadline: 13 May 2024
For more information click: https://idrc-crdi.ca/en/funding/call-letters-interest-addressing-neglected-areas-sexual-and-reproductive-health-and-rights
Scientific Concepts for SANTHE Fellowships (DELTAS Africa)
Scientific project concepts should be for basic, social and clinical or translational science research projects that are focused on HIV and/or TB and associated morbidities. This is a 2 step process consisting on 1) selection of scientific project proposals 2) Recruitment of trainees. University of Zimbabwe is recruiting 1 Postdoctoral fellow.
Deadline: 15 May 2024
To apply click: https://www.cognitoforms.com/ahri1/scientificprojectconceptapplicationdeltasafrica2024
SANTHE Mini Career Development Award
These awards (up to a maximum of $10,000 USD) are accepted on a rolling basis and are designed to help assist early/mid-career researchers to establish new collaborations and initiate new scientific projects. They may also be used for training at international sites.
Any SANTHE Post-doctoral researcher, path-to-independence awardee, or SANTHE supervisor, or working group member may apply.
To apply click: https://www.cognitoforms.com/ahri1/minicareerdevelopmentaward
The Pandemic Fund
The Pandemic Fund has opened its second Call for Proposals (CfP) on December 22, 2023 and is inviting interested Eligible Countries, Regional Entities, and Implementing Entities to develop full proposals for potential projects to be supported by this initial funding. In recognition of the high demand for funding demonstrated in the first CfP, the second CfP continues to prioritize high-impact investments in: 1) early warning and disease surveillance systems, 2) laboratory systems, and 3) strengthening human resources/public health and community workforce capacity, including workforce capacity related to human and animal health, to help countries prevent, prepare for and respond to health emergencies.
Deadline: 17 May 2024
For more information click: https://www.worldbank.org/en/programs/financial-intermediary-fund-for-pandemic-prevention-preparedness-and-response-ppr-fif/funding-opportunities
Wellcome Early-Career Awards
This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding related to human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme.
Due dates: 21 May and 1 October 2024
For more information click: https://wellcome.org/grant-funding/schemes/early-career-awards
Africa-Europe Foundation
The Africa-Europe Foundation is pleased to announce a Call for Proposals to establish a multiannual research partnership from July 2024 to December 2025. This Call for Proposals is underpinned by the “State of Africa-Europe Report 2024”, produced by the Africa-Europe Foundation and providing a unique benchmarking exercise on the implementation of the Africa-Europe Partnership, including review of the existing policy/financial commitments of the political partnership between the African Union and the European Union.
This Call invites research organisations to deep dive into 3 priority chapters from the ‘State of Africa-Europe Report 2024’, specifically the chapters on:
- Sustainable Finance;
- Climate and Development;
- Science, Education, and Culture.
The Call will serve to establish an “Africa-Europe Research Consortium”, consisting of research organisations from Africa and Europe, including think tanks, research institutes, universities as well as CSOs/NGOs and social enterprises with proven track record in research and policy.
Due date: 23 May 2024
For more information click: https://www.africaeuropefoundation.org/areas-of-action/call-for-proposals-2024:-research/
AGHRB: Malaria vaccine implementation studies in Africa
Apply for funding to undertake implementation research to understand the optimal strategies for roll-out and scale up of the malaria vaccines RTS,S and R21 to ensure that they are deployed in the most effective and equitable way for population health benefit. Research should be conducted in at least two Sub-Saharan African countries, one of which should have a high malaria burden. We will accept applications of all sizes, including large research projects and small to medium-scale applications. You must firstly submit a pre-application to apply for this funding opportunity. Following MRC confirmation your project is within remit, you will be invited to submit a full application.
Due date: 3 June 2024
For more information click: https://www.ukri.org/opportunity/aghrb-malaria-vaccine-implementation-studies-in-africa/
New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
The purpose of this funding opportunity is to encourage multidisciplinary investigators to develop new approaches or apply existing approaches in novel ways to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment. The overarching goal is to extend our understanding of brain development and aging, including studies of the neurodevelopmental origins of later health and disease. Research can include healthy human participants of any age; specific clinical groups such as those with cognitive, motor, or affective regulation challenges; and/or animal research on these domains of function. The studies can focus on longitudinal neuroanatomical or functional changes at any level, including genetics/genomics, single cells, connectomics, neural population activity patterns, and others. This funding opportunity is intended to encourage technological and conceptual innovation to improve repeated measures across longer epochs of the lifespan, to better predict outcomes at later ages. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.
Due dates: 5 June and 5 October 2024
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-160.html
Applied global health research: stage one
We’re looking to fund research projects that will lead to tangible change in health policy and practice in the near future through practical, impact focused research. Through our investments in global health research, we aim to:
- support a portfolio of high quality, high priority, diverse investments to improve health, encouraging:
o innovation in study design
o multi-disciplinarity to address global challenges
o diverse health topics: prioritise local relevance with potential for global impact
- prioritise equitable partnerships
- invest in research capacity strengthening
- promote co-design and co-production with communities, policy-makers and health practitioners
Due date: 13 June 2024
For more information click: https://www.ukri.org/opportunity/applied-global-health-research/
GenScript Life Science Research Grant Program
GenScript Life Science Research Grant Program is a new initiative dedicated to supporting breakthroughs in life science research areas, including but not limited to those indicated below. This program is designed to empower researchers by providing grant funding earmarked explicitly for purchasing GenScript reagents and services.
- Gene and Cell Therapy Development
- Antibody Drug Discovery
- Vaccine Development
Deadlines: 15 June, 15 September, 15 November 2024
For more information click: https://www.genscript.com/grantprogram.html
New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
The purpose of this funding opportunity is to encourage multidisciplinary investigators to develop exploratory, highly novel new approaches, or innovative applications of existing approaches, to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment. The overarching goal is to extend our understanding of brain development and aging, including studies of the neurodevelopmental origins of later health and disease, by improving repeated measures across longer epochs of the lifespan to better predict outcomes at later ages. Research can include healthy human participants of any age; specific clinical groups such those with cognitive, motor, or affective regulation challenges; and/or animal research on these domains of function. The studies can focus on longitudinal neuroanatomical or functional changes at any level, including genetics/genomics, single cells, connectomics, neural population activity patterns, and others. This funding opportunity is intended to encourage technological and conceptual innovation through this high risk, high reward funding mechanism to develop highly innovative ideas that either lack preliminary data or need additional preliminary data. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.
Due dates: 16 June and 16 Oct 2024
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-161.html
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (“de-implement”) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services (e.g. cancer screening) that may have dropped off amidst the ongoing COVID pandemic are encouraged.
Due dates: 16 June and 16 Oct 2024
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-109.html
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (“de-implement”) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services (e.g. cancer screening) that may have dropped off amidst the ongoing COVID pandemic are encouraged.
Due dates:16 June and 16 Oct 2024
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-106.html
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
This FOA encourages applications from institutions/organizations that propose to conduct vision-related secondary data analyses utilizing existing database resources. Applications may be related to, but must be distinct from, the specific aims of the original data collection. The NEI supports an extensive portfolio of clinical trials and large-scale epidemiologic research projects wherein numerous data collection activities are required to meet each project’s specific aims. The resultant wealth of data generated by these studies often provides unique, cost-effective opportunities to investigate additional research questions or develop new analytical approaches secondary to a project’s originally-intended purpose. Data are not limited to those collected under NEI support, but such data are of the highest programmatic interest. The purpose of this FOA is for secondary data analysis using existing data sets from vision-related clinical trials, epidemiologic, and other clinical research studies. This FOA may be used to develop new statistical methodologies or test hypotheses using existing data, but this FOA must not be used to support the collection of new data.
Due dates:16 June and 16 Oct 2024
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-141.html
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)
The NIH Common Fund has established the Gabriella Miller Kids First Pediatric Research Program (Kids First) to develop a pediatric research data resource populated by genome sequence and phenotypic data that will be of high value for the communities of investigators who study the genetics of childhood cancers and/or structural birth defects.Kids First has established and continues to develop a Data Resource including a collection of curated genomic and phenotypic data from childhood cancer and structural birth defects cohorts and a central portal where these data and analysis tools are accessible to the research community. Access to these data will promote comprehensive and cross-cutting research and collaboration leading to more refined diagnostic capabilities and ultimately more targeted therapies. This FOA is intended to support meritorious small research projects focused on analyses of childhood cancer and/or structural birth defects genomic datasets generated by the Kids First program and/or associated phenotypic datasets. Development of approaches, tools, or algorithms appropriate for analyzing genomic, phenotypic, and/or clinical data relevant to Kids First may also be proposed.
Due dates: 16 June and 16 Oct 2024
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-075.html
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should account for interdependencies across scales of biological, social, and ecological organization, make extensive use of theory, modeling, and validation with available large-scale datasets, and may be interdisciplinary drawing from the natural and social sciences.
Due dates: 16 June and 16 Oct 2024
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-301.html
Alcohol Health Services Research (R34 Clinical Trial Optional)
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.
Due dates: 16 June and 16 Oct 2024
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-252.html
Global Health Policy and Systems Research (HPSR) Projects Call 2
The programme aims to support applied research to strengthen health policy and health systems through:
- high quality research on health policy, health services and health systems which improves outcomes for the most vulnerable people in LMICs and addresses issues of health equity
- addressing applied health policy and systems research questions which target challenges or evidence gaps prioritised by local stakeholders and policymakers
- supporting equitable partnerships and networks between researchers to generate new research knowledge and evidence
- involvement and engagement with policymakers, communities, patients and the public, and civil society organisations throughout the research lifecycle
- delivering evidence to inform policy and/or practice, for example through engaging with policymakers and informing local, regional or national strategies
- capacity strengthening plans for individuals and institutions in LMICs which are proportionate and relevant to the delivery of the proposed activities
- including appropriate project management and financial/administrative support
- supporting career development for research leaders of the future, i.e. by giving less experienced researchers in LMICs the opportunity to lead or jointly lead on the research proposal with effective mentoring and appropriate support
Due date: 19 June 2024
For more information click: https://www.nihr.ac.uk/funding/global-health-policy-and-systems-research-hpsr-projects-call-2/35549
U21 HSG Funding Opportunities
We offer staff and research students a range of funding options for collaborative projects. We strongly encourage our members to take an interdisciplinary approach involving multiple health themes, working in partnership with at least three member universities. We are pleased to offer three different funding options which include:
- international Projects Fund
- Research Development Fund
- Student Research Fund
Due date: 21 June 2024
For more information click: https://u21health.org/funding-opportunities
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)
This Notice of Funding Opportunity (NOFO) solicits applications to develop web-accessible data archives to capture, store, and curate data related to the Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative activities. The data archives teams will work with the research community to incorporate software tools that allow users to analyze and visualize the data, and will use appropriate standards to describe the data, but an application with major focus on the creation of such software tools and data standards is not responsive to this NOFO. A goal of this program is to advance research by creating a data archive with appropriate standards and summary information that is broadly available and accessible to the research community for furthering research. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.
Due dates: 24 June 2024
For more information click: https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-25-110.html
Infectious Disease Award: Understanding dengue and Zika spread, immunity and clinical outcomes
This funding call will support multidisciplinary teams to generate evidence on where dengue and Zika viruses co-circulate and investigate the implications this has on host immune responses and clinical outcomes. Research funded through this award will support global efforts to understand and predict the spread of these pathogens, especially where data are limited. Funded projects will also help to design and implement future interventions to reduce dengue and Zika’s growing burden and impact on health.
Due date: 25 June 2024
For more information click: https://wellcome.org/grant-funding/schemes/infectious-disease-award-understanding-dengue-and-zika-spread
Leveraging Data at Scale to Understand Natural Product Impacts on Whole Person Health (R01 Clinical Trial Not Allowed)
This notice of funding opportunity (NOFO) will support development, adaptation, and/or applications of computational tools to aggregate and analyze orthogonal chemical and/or biological data sets related to natural products with the aim of generating novel testable hypotheses regarding their biological activity and role in the context of whole person health research. Projects must leverage and merge multiple compatible or interoperable sources and/or types of data. Use of artificial intelligence and machine learning approaches is encouraged. This NOFO is part of the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. Other components of this Program include the Botanical Dietary Supplements Translational Research Teams (RM1) and RFA-AT-24-007 Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data (R24).
Due date: 28 June 2024
For more information click: https://grants.nih.gov/grants/guide/rfa-files/RFA-AT-24-008.html
The Conservation, Food & Health Foundation
The Conservation, Food and Health Foundation seeks to protect the environment, improve food production, and promote public health in Africa, Asia, the Caribbean, Latin America, and the Middle East.
In all of its areas of interest, the Foundation gives priority to projects that have the potential to advance the field, build local capacity, promote replication, influence public opinion and policy, affect systems change, and benefit people beyond the immediate project and its local context.
Due dates: 1 July 2024
For more information click: https://cfhfoundation.grantsmanagement08.com/
Wellcome Career Development Awards
This scheme provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding related to human life, health and wellbeing.
Due date: 25 July 2024
For more information click: https://wellcome.org/grant-funding/schemes/career-development-awards
Wellcome Discovery Awards
This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing.
Due date: 30 July 2024
For more information click: https://wellcome.org/grant-funding/schemes/discovery-awards
Optimizing Health of Children and Adolescents with Perinatal HIV Exposure (U19 Clinical Trial Optional)
This Notice of Funding Opportunity (NOFO) invites applications to participate in a research program cooperative agreement to support the Optimizing Health of Children and Adolescents with Perinatal HIV Exposure Initiative. The objective of this NOFO is to generate information needed to develop and to test interventions for the early detection and reduction of long-term effects of in utero/perinatal exposure to antiretroviral therapy (ART) and/or HIV among individuals who are HIV exposed but uninfected (IHEU). Investigators with innovative thinking and new approaches to address the public health issues facing IHEUs are encouraged to apply. A multi-program project grant is proposed to answer questions not easily addressed in an R01 or U01. The applications should answer important fundamental questions related to long-term health outcomes for IHEUs. Proposed projects should 1) have a scope that is well matched to the resources and the research objectives, 2) be scientifically meritorious, and 3) complement one another, be synergistic, and support the program’s overall theme.
Due date: 30 July 2024
For more information click: https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-25-004.html
Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services (R34 Clinical Trial Optional) – RFA-DA-25-018
The goal of this notice of funding opportunity (NOFO) is to support exploratory research and preliminary interventions to address the interrelated and compounding contextual factors that contribute to substance use and HIV risk among survivors of sex trafficking. This would be accomplished through research that builds new interventions and models of care that can effectively engage survivors of sex trafficking in care for substance use disorder (SUD), HIV, trauma, and other mental health outcomes and addresses key structural and social determinants of health that contribute to risk for sexual trafficking, as well as barriers to and facilitators of escaping continued exploitation. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.
Due date: 5 August 2024
For more information click: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-018.html
Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance Use and Mental Health Disorders (R01 Clinical Trial Required)
This notice of funding opportunity (NOFO) seeks applications that coordinate efforts to simultaneously characterize the effects of neuromodulation on brain circuits and behaviors relevant to both substance use disorder (SUD) and mental health disorder (MHD) . Proposed studies are expected to provide a mechanistic perspective on the shared and unique pathophysiology related to SUD and MHD through the causal manipulation of relevant circuit(s) via targeted neuromodulation in human participants. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.
Due date: 15 August 2024
For more information click: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-035.html
Merck Stimulating Innovative Research
Since 2018, we are offering a series of research grants to stimulate innovative research in challenging areas of future importance. Grants of up to 500,000 € per year for up to 3 years have been made available. In 2024, grants are available in the area as further specified below.
- Discovery strategies for molecular glue degraders and other protein-protein-interaction stabilizers – 1 grant comprising up to 100,000 €/year for up to 3 years with potential further collaboration
- Augmented Reality Digital Twin – 1 grant comprising up to 120,000 €/year for 1 year with potential further collaboration
- AI-Driven Drug Discovery – up to 3 grants comprising AIDDISON software licenses for one year with potential further collaboration
Due date: 31 August 2024
For more information click: https://www.merckgroup.com/en/research/open-innovation/research-grants.html
Roddenberry Foundation’s Catalyst Fund
The Roddenberry Foundation is seeking applications for its Catalyst Fund. The stages are;
- Early Stage: The Catalyst Fund is geared towards small and/or early-stage ideas and projects that need a capital infusion to launch or prove viability. Catalyst awardees are typically piloting a program, venturing into new territory, on the cusp of launching, or pivoting in a new direction.
- Big Ideas: The Catalyst Fund supports big ideas or projects that depart from the status quo and require us to look at a problem and its solution in a new light. These big ideas have a high potential for impact across an entire community, city, or country. They tend to leverage existing infrastructure, build on partnerships (public and private), and improve on what’s already out there.
Big ideas push boundaries and challenge convention.
- Bold Vision: The Catalyst Fund supports individuals whose vision for change is audacious. Catalyst awardees seek significant, long-term impact and have a vision for how to get there and what needs to get done. They are able to articulate how they plan to make the world better and why. Their vision inspires others and offers a glimpse of a better future.
Due date: Applications are accepted all year round.
For more information click: https://roddenberryfoundation.org/our-work/catalyst-fund/
Fund for Innovation in Development Grants
The Fund for Innovation in Development (FID) is inviting innovators and researchers from around the world to apply for grant funding to more effectively or efficiently address poverty and inequality.
Through flexible grant funding, FID enables innovators and researchers to test new ideas, build rigorous evidence of what works, and scale the highest-impact and most cost- effective solutions.
Due date: Applications are accepted all year round.
For more information click: https://fundinnovation.dev/en
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for research training programs to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research relevant to the evolving HIV epidemic in their country. This FOA can support training for conducting research in a broad range of HIV research areas across HIV prevention, treatment, care, and quality of life continuum. This includes basic, epidemiologic, clinical, behavioral and social sciences, data science, community-based, implementation, operations, health services, and health systems research. Cross-disciplinary research as well as HIV associated comorbidities and coinfections affecting the HIV epidemic will be supported under this FOA. An application should focus the proposed training program to strengthen research capacity in a defined high priority HIV scientific area aligned with NIH HIV/AIDS research priorities (NOT-OD-20-018) at a specific LMIC institution and collaborating LMIC partner institutions.
Due date: 22 August 2024
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-151.html
Fellowships and Scholarships
Africa Research Excellence Fund (AREF)
The AREF Towards Leadership programme aims to empower talented, emerging scientists in Africa to compete successfully for UKRI MRC and other major funding opportunities in global health research. Together we are investing in talented African scientists in Africa, enhancing their global health research and leadership potential. The programme will run between Oct 2024 to Oct 2025, consisting of two residential workshops (opening and closing) and one virtual workshop. The curriculum is designed to support engage and enhance the participants’ capabilities and to empower talented, emerging scientists in Africa to compete successfully on a level playing field for UKRI MRC and other major funding opportunities in global health research. The programme is directed towards to winning grant funding, empowering effective teams, collaborating internationally, influencing stakeholders, and building rewarding research careers.
Deadline for applications: 6 May 2024
For more information, click: https://africaresearchexcellencefund.org.uk/funding-calls/the-aref-mrc-towards-leadership-programme/
Joint Postdoctoral Fellowship in Ethics, Global Health and Infectious Disease
The Johns Hopkins Berman Institute of Bioethics and the Wellcome Centre for Ethics and Humanities at the University of Oxford have established a Collaborative Bioethics Research and Training Program with support from the Wellcome Trust. Through this partnership, we have created joint post-doctoral training opportunities. We are pleased to invite applications from uniquely qualified individuals who are committed to interdisciplinary and transnational collaboration and who have a particular interest in the ethical issues at the intersection of global health and infectious disease. This two-year fellowship will begin September 1, 2024. Deadline: 10 May 2024
For more information click: https://apply.interfolio.com/143815
TWAS-DFG Cooperation Visits Programme – SSA
The TWAS-DFG Cooperation Visits Programme provides postdoctoral researchers from sub-Saharan Africa, including South Africa, with the opportunity to make a three-month ‘Cooperation Visit’ to a research institute in Germany. Such visits must be undertaken within 12 months of the award. The aim of the visit is to initiate research collaboration between African and German scientists with the ultimate goal of developing longer-term links, perhaps through other Deutsche Forschungsgemeinschaft (DFG, or German Research Foundation) programmes. DFG will cover travel expenses and provide subsistence costs for the stay in Germany. The administration and financial operation of TWAS is undertaken by UNESCO in accordance with an agreement signed by the two organizations.
Application deadlines: 5 June 2024.
For more information click: https://www.twas.org/opportunity/twas-dfg-cooperation-visits-programme-ssa
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-106.html
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
This FOA encourages applications from institutions/organizations that propose to conduct vision-related secondary data analyses utilizing existing database resources. Applications may be related to, but must be distinct from, the specific aims of the original data collection. The NEI supports an extensive portfolio of clinical trials and large-scale epidemiologic research projects wherein numerous data collection activities are required to meet each project’s specific aims. The resultant wealth of data generated by these studies often provides unique, cost-effective opportunities to investigate additional research questions or develop new analytical approaches secondary to a project’s originally-intended purpose. Data are not limited to those collected under NEI support, but such data are of the highest programmatic interest. The purpose of this FOA is for secondary data analysis using existing data sets from vision-related clinical trials, epidemiologic, and other clinical research studies. This FOA may be used to develop new statistical methodologies or test hypotheses using existing data, but this FOA must not be used to support the collection of new data.
Due dates: 16 Feb, 16 June and 16 Oct 2024
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-141.html
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)
The NIH Common Fund has established the Gabriella Miller Kids First Pediatric Research Program (Kids First) to develop a pediatric research data resource populated by genome sequence and phenotypic data that will be of high value for the communities of investigators who study the genetics of childhood cancers and/or structural birth defects.Kids First has established and continues to develop a Data Resource including a collection of curated genomic and phenotypic data from childhood cancer and structural birth defects cohorts and a central portal where these data and analysis tools are accessible to the research community. Access to these data will promote comprehensive and cross-cutting research and collaboration leading to more refined diagnostic capabilities and ultimately more targeted therapies. This FOA is intended to support meritorious small research projects focused on analyses of childhood cancer and/or structural birth defects genomic datasets generated by the Kids First program and/or associated phenotypic datasets. Development of approaches, tools, or algorithms appropriate for analyzing genomic, phenotypic, and/or clinical data relevant to Kids First may also be proposed.
Due dates: 16 Feb, 16 June and 16 Oct 2024
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-075.html
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should account for interdependencies across scales of biological, social, and ecological organization, make extensive use of theory, modeling, and validation with available large-scale datasets, and may be interdisciplinary drawing from the natural and social sciences.
Due dates: 16 Feb, 16 June and 16 Oct 2024
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-301.html
Alcohol Health Services Research (R34 Clinical Trial Optional)
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.
Due dates: 16 Feb, 16 June and 16 Oct 2024
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-252.html